Shell’s latest valuation update shows fair value nudging down from €31.43 to €31.31, with the unchanged 7.07% discount rate underscoring a steady view of risk even as long term revenue growth ...
Shares in Tokyo-listed Nxera Pharma slid 5% at market open after Boehringer walked away from the neurological assets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback